However, since obtaining CSF from SLE patients without overt neuropsychiatric manifestations is hindered by practical and ethical issues, non-invasive assessment of the integrity of the BBB opens an attractive research direction to study anti-NR2A/B antibody mediated cognitive dysfunction in SLE patients. This evidence concerns the gene GRIN2A and systemic lupus erythematosus.